# Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells

> **NCT01337011** · NA · TERMINATED · sponsor: **Asklepios proresearch** · enrollment: 10 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** autologous CD133pos stem cell application

## Key facts

- **NCT ID:** NCT01337011
- **Lead sponsor:** Asklepios proresearch
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2016-03-02
- **Final completion:** 2017-07-17
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** study was stopped due to funding issues
- **Last updated:** 2021-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337011, "Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01337011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*